QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Résumé Extracto Full Text PDF Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Borrás-Blasco, J. Articles by González-Delgado, M. Search for Related Content PubMed PubMed Citation Articles by Borrás-Blasco, J. Articles by González-Delgado, M.

Photo-Induced Stevens–Johnson Syndrome Due to Sulfasalazine Therapy

Specialist in Hospital Pharmacy, Pharmacy Service, Hospital General Universitario de Elche, Elche, Alicante, Spain

Andrés Navarro-Ruiz, PharmD

Specialist in Hospital Pharmacy, Pharmacy Service, Hospital General Universitario de Elche

Jaime Matarredona, MD

Specialist in Dermatology, Dermatology Section, Hospital General Universitario de Elche

Pedro Devesa, MD

Specialist in Dermatology, Dermatology Section, Hospital General Universitario de Elche

Amparo Montesinos-Ros, PharmD

Resident in Hospital Pharmacy, Pharmacy Service, Hospital General Universitario de Elche

Mercedes González-Delgado, PharmD

Specialist in Hospital Pharmacy, Director of Pharmacy Service, Hospital General Universitario de Elche

Reprints: Joaquín Borrás-Blasco PharmD PhD, Servicio de Farmacia, Hospital General Universitario de Elche, Camí de l'Almazara 11, Elche 03203 (Alicante) Spain, FAX 34 966679162, jborrasb{at}sefh.es

OBJECTIVE: To report a case of photo-induced Stevens–Johnson Syndrome (SJS) due to sulfasalazine therapy.

CASE SUMMARY: Photo-induced SJS associated with sulfasalazine therapy occurred in a 34-year-old white man diagnosed as having seronegative symmetrical polyarthritis with no predisposing factors. According to his medical record, the patient had received methotrexate, levofolinate calcium, deflazacort, and diclofenac sodium as needed. Two months prior to admission, methotrexate and diclofenac sodium were suspended and treatment with sulfasalazine was started. The patient presented to our emergency department because of severe erythema confined to sun-exposed areas; annular lesions on the extremities and the mucosa were affected. Nikolskyís sign was present. A skin biopsy was compatible with SJS, and the clinical diagnosis was SJS induced by sulfasalazine. Administration of sulfasalazine was suspended, which resulted in an improvement in the skin lesions and general state of health. The patient was discharged without further symptoms.

DISCUSSION: The observed reaction to sulfasalazine was considered phototoxic, as lesions appeared like a burn rash reaction in sun-exposed areas when sulfasalazine treatment was started and the reaction progressed to SJS. It seems that there was a correlation between the time course of the reaction and the administration of sulfasalazine. An objective causality assessment revealed that the adverse effect was possible.

CONCLUSIONS: To our knowledge, this is the first report of photo-induced SJS due to sulfasalazine therapy. Clinicians should be aware of this infrequent but severe reaction. If clinical evaluation leads to the suspicion of SJS, sulfasalazine should be discontinued immediately.

Key Words: phototoxicity, Stevens–Johnson syndrome, sulfasalazine

Published Online, July 2, 2003. www.theannals.com, DOI 10.1345/aph.1C271

This article has been cited by other articles:

				J. Borras-Blasco, A. Navarro-Ruiz, C. Borras, and E. Castera Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection J. Antimicrob. Chemother., November 1, 2008; 62(5): 879 - 888. [Abstract] [Full Text] [PDF]